Welcome
Support Centre
30 July 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Does intramedullary plugging reduce blood transfusion requirements in total knee replacement?
ISRCTN ISRCTN94713892
ClinicalTrials.gov identifier N/A
Public title Does intramedullary plugging reduce blood transfusion requirements in total knee replacement?
Scientific title Does intramedullary plugging reduce blood transfusion requirements in total knee replacement?: A randomised controlled clinical trial
Acronym N/A
Serial number at source Version 1, dated 24.08.09
Study hypothesis To assess if intramedullary plugging, when used together with an autologous retransfusion drain, reduces blood loss to make significant differences in allogenic blood requirements in patients undergoing total knee replacement
Ethics approval Berkshire Research Ethics Committee (REC) approved on the 20th November 2009 (ref: 09/H0505/117)
Study design Randomised controlled parallel group trial
Countries of recruitment United Kingdom
Disease/condition/study domain Trauma and Orthopaedics - total knee replacements
Participants - inclusion criteria Both male and female patients, aged 50-90 years, undergoing primary total knee replacement surgery
Participants - exclusion criteria Patients undergoing unicompartmental knee replacements and revision knee replacements
Anticipated start date 24/12/2009
Anticipated end date 30/01/2011
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 100
Interventions Patients who have total knee arthroplasty will be randomised into two groups. One group will have intramedullary plugging with retransfusion drains and one group will have retransfusion drains only.
Primary outcome measure(s) Allogenic blood transfusion requirements
Secondary outcome measure(s) Post-operative blood loss assessed by:
1. Haemoglobin levels in first 3-days of the post-operative period
2. Total amount of blood collected in drain in the first 24 hours after surgery
Sources of funding Royal Berkshire NHS Foundation Trust (UK) - Trauma and Orthopaedic Department
Trial website
Publications
Contact name Mr  Shawn  Tavares
  Address Consultant Orthopaedic Surgeon
Trauma and Orthopaedic Department
Royal Berkshire NHS Foundation Trust
London Road
  City/town Reading
  Zip/Postcode RG1 5AN
  Country United Kingdom
Sponsor Royal Berkshire NHS Foundation Trust (UK)
  Address c/o Leslie Frederick
Research and Development Office
Royal Berkshire NHS Foundation Trust
London Road
Reading
  City/town Reading
  Zip/Postcode RG1 5AN
  Country United Kingdom
Date applied 18/12/2009
Last edited 09/02/2010
Date ISRCTN assigned 09/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central